HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
Zacks Rank    Equity Research    Premium Home    My Account    Help    
Quote:
Login Free Membership
Search:

Analyst Blog  

Orchid Cellmark to Bloom

Share
January 06, 2009 |Comments: 0
Recommended this article (0)

Orchid Cellmark Inc. (ORCH) is a leading provider of DNA testing services for forensic, human identity and agricultural applications in the U.S. and the U.K. The company is also the world's largest provider of "scrapie susceptibility genotyping."

The company expanded its reach in the U.S. with the acquisition of ReliaGene in October 2007. The company is now leveraging its expertise in DNA testing to enter into new markets like pork traceability, immigration testing and security applications.

Orchid Cellmark has won a major part of the mega-tender in the U.K., which will result in annual revenues of $10 million for the next 3 years. As such, we maintain our Buy rating on the stock with a revised target price of $2.50.

Maharathi Basu contributed to this report.

Read the full analyst report on ORCH


Read the full analyst report on ORCH

 
Add a Comment

Please login or register to post a comment


Email

Print

Share

Rate Pos

Rate Neg

Comment

More Zacks Resources

Market Summary Feb 10, 2012 10:37 am ET
DJIA 12779.77  -110.69 -0.86%
NASD 2908.19  -19.04 -0.65%
S&P 500 1341.49  -10.46 -0.77%
Partner Center